4//SEC Filing
Kaplin Adam 4
Accession 0001493152-21-009409
CIK 0001321834other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 9:53 PM ET
Size
5.9 KB
Accession
0001493152-21-009409
Insider Transaction Report
Form 4
Kaplin Adam
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-16+154,360→ 154,360 totalExercise: $2.59Exp: 2023-04-16→ Common Stock (154,360 underlying)
Footnotes (2)
- [F1]Received in exchange for a stock option to acquire 400,000 shares of common stock of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share.
- [F2]These options are fully vested and exercisable.
Documents
Issuer
MyMD Pharmaceuticals, Inc.
CIK 0001321834
Entity typeother
Related Parties
1- filerCIK 0001858042
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 9:53 PM ET
- Size
- 5.9 KB